The relation between serum levels of osteoprotegerin and postoperative epidural fibrosis in patients who underwent surgery for lumbar disc herniation

Neurol Res. 2005 Jun;27(4):452-5. doi: 10.1179/016164105X15631.

Abstract

Objectives: Epidural fibrosis (EF) is a part of the normal physiological tissue response to laminectomy and it is an important cause of failed back surgery syndrome (FBSS). Osteoprotegerin (OPG) is a soluble member of the tumor necrosis factor receptor family, and is expressed in high concentrations by a variety of tissues and cell types. The objective of this study was to evaluate the relationship between serum OPG levels, and the existence of postoperative EF in patients with lumbar disc herniation. It has been suggested that cytokines and growth factors, which play a role in the wound healing, may enhance the expression of OPG.

Methods: Forty women who underwent surgery for lumbar disc herniation were included in this study. Postoperative MRI was performed to assess EF in all patients.

Results: The serum OPG levels of subjects with postoperative EF were significantly higher than those of subjects without postoperative EF (4.72 +/- 0.27 versus 3.25 +/-0.41 pmol/l; p=0.005)

Discussion: Although the role of OPG in the development of EF is poorly understood, our results suggest that elevated levels of serum OPG are associated with and may play a role in the pathogenesis of fibrotic process.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Absorptiometry, Photon / methods
  • Adult
  • Aged
  • Bone Density
  • Enzyme-Linked Immunosorbent Assay / methods
  • Epidural Space / metabolism*
  • Female
  • Fibrosis / blood*
  • Fibrosis / etiology
  • Glycoproteins / blood*
  • Humans
  • Intervertebral Disc Displacement / complications*
  • Intervertebral Disc Displacement / surgery
  • Lumbosacral Region / surgery
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neurosurgical Procedures / methods
  • Osteoprotegerin
  • Postoperative Period*
  • Receptors, Cytoplasmic and Nuclear / blood*
  • Receptors, Tumor Necrosis Factor / blood*
  • Treatment Outcome

Substances

  • Glycoproteins
  • Osteoprotegerin
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Tumor Necrosis Factor
  • TNFRSF11B protein, human